Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis

&NA; Rationale: Differences in the lung microbial community influence idiopathic pulmonary fibrosis (IPF) progression. Whether the lung microbiome influences IPF host defense remains unknown. Objectives: To explore the host immune response and microbial interaction in IPF as they relate to progression‐free survival (PFS), fibroblast function, and leukocyte phenotypes. Methods: Paired microarray gene expression data derived from peripheral blood mononuclear cells as well as 16S ribosomal RNA sequencing data from bronchoalveolar lavage obtained as part of the COMET‐IPF (Correlating Outcomes with Biochemical Markers to Estimate Time‐Progression in Idiopathic Pulmonary Fibrosis) study were used to conduct association pathway analyses. The responsiveness of paired lung fibroblasts to Toll‐like receptor 9 (TLR9) stimulation by CpG‐oligodeoxynucleotide (CpG‐ODN) was integrated into microbiome‐gene expression association analyses for a subset of individuals. The relationship between associated pathways and circulating leukocyte phenotypes was explored by flow cytometry. Measurements and Main Results: Down‐regulation of immune response pathways, including nucleotide‐binding oligomerization domain (NOD)‐, Toll‐, and RIG1‐like receptor pathways, was associated with worse PFS. Ten of the 11 PFS‐associated pathways correlated with microbial diversity and individual genus, with species accumulation curve richness as a hub. Higher species accumulation curve richness was significantly associated with inhibition of NODs and TLRs, whereas increased abundance of Streptococcus correlated with increased NOD‐like receptor signaling. In a network analysis, expression of up‐regulated signaling pathways was strongly associated with decreased abundance of operational taxonomic unit 1341 (OTU1341; Prevotella) among individuals with fibroblasts responsive to CpG‐ODN stimulation. The expression of TLR signaling pathways was also linked to CpG‐ODN responsive fibroblasts, OTU1341 (Prevotella), and Shannon index of microbial diversity in a network analysis. Lymphocytes expressing C‐X‐C chemokine receptor 3 CD8 significantly correlated with OTU1348 (Staphylococcus). Conclusions: These findings suggest that host‐microbiome interactions influence PFS and fibroblast responsiveness.

[1]  Brent S. Pedersen,et al.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.

[2]  D. O’Dwyer,et al.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[3]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[4]  G. Huffnagle,et al.  The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease , 2015, PLoS pathogens.

[5]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[6]  L. Joosten,et al.  Receptor Recognition of and Immune Intracellular Pathways for Veillonella parvula Lipopolysaccharide , 2009, Clinical and Vaccine Immunology.

[7]  J. Doré,et al.  Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut , 1999, Applied and Environmental Microbiology.

[8]  W. Seeger,et al.  Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin , 2015, Thorax.

[9]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[10]  K. Anstrom,et al.  TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. , 2015, American journal of respiratory and critical care medicine.

[11]  K. I. Ugland,et al.  The species–accumulation curve and estimation of species richness , 2003 .

[12]  D. Sin,et al.  Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease. , 2015, American journal of respiratory and critical care medicine.

[13]  A. Nicholson,et al.  Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. , 2009, The Journal of clinical investigation.

[14]  D. Sheppard,et al.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.

[15]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[16]  Meilan K. Han,et al.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. , 2014, The Lancet. Respiratory medicine.

[17]  K. Anstrom,et al.  TOLLIP , MUC 5 B , and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis , 2015 .

[18]  D. Riches,et al.  ROCK and Rho: Promising therapeutic targets to ameliorate pulmonary fibrosis. , 2015, The American journal of pathology.

[19]  I. Noth,et al.  Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. , 2013, JAMA.

[20]  I. Noth,et al.  A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis , 2015, BMC Pulmonary Medicine.

[21]  A. Nicholson,et al.  Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.

[22]  P. Weinreb,et al.  Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). , 2009, The American journal of pathology.

[23]  J. Farrar,et al.  Human TOLLIP Regulates TLR2 and TLR4 Signaling and Its Polymorphisms Are Associated with Susceptibility to Tuberculosis , 2012, The Journal of Immunology.

[24]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[25]  K. Janardhan,et al.  Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. , 2006, Histology and histopathology.

[26]  Naftali Kaminski,et al.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.

[27]  K. Anstrom,et al.  A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.

[28]  Jeffrey L. Curtis,et al.  Changes in the Lung Microbiome following Lung Transplantation Include the Emergence of Two Distinct Pseudomonas Species with Distinct Clinical Associations , 2014, PloS one.

[29]  F. Martinez,et al.  TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis , 2010, Science Translational Medicine.

[30]  H. Chan,et al.  Lymphocyte CFTR promotes epithelial bicarbonate secretion for bacterial killing , 2012, Journal of cellular physiology.

[31]  H. Collard,et al.  A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. , 2010, The New England journal of medicine.

[32]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[33]  F. Martinez,et al.  The Microbiome and the Respiratory Tract. , 2016, Annual review of physiology.

[34]  Ivana V. Yang,et al.  Muc5b is required for airway defence , 2013, Nature.

[35]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[36]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[37]  Gordon Cooke,et al.  The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.

[38]  Anna-Lu.  Epithelial Necrosis and Alveolar Collapse in the Pathogenesis of Usual Interstitial Pneumonia , 2006 .

[39]  F. Martinez,et al.  TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation , 2008, Histochemistry and Cell Biology.

[40]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[41]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Nicola J. Rinaldi,et al.  Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation , 2008 .

[43]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[44]  Chen-Yong Lin,et al.  Rho GTPases mediated integrin αvβ3 activation in sphingosine-1-phosphate stimulated chemotaxis of endothelial cells , 2008, Histochemistry and Cell Biology.

[45]  N. Kaminski,et al.  CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis , 2010, PloS one.

[46]  M. Selman,et al.  Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. , 1995, The American journal of physiology.

[47]  R. Chambers,et al.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. , 2006, The Journal of clinical investigation.

[48]  Jong-Suk Kim,et al.  Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway , 2008, European Respiratory Journal.

[49]  Ivana V. Yang,et al.  The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis , 2012, PloS one.

[50]  F. Sinigaglia,et al.  Thrombopoietin Complements Gi- but Not Gq-dependent Pathways for Integrin αIIbβ3 Activation and Platelet Aggregation* , 2005, Journal of Biological Chemistry.

[51]  Takashi Yamamoto,et al.  Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse , 2005, Cell and Tissue Research.

[52]  George C Tseng,et al.  Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis , 2013, Science Translational Medicine.

[53]  R. D. du Bois,et al.  Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. , 2011, Chest.

[54]  Meilan K. Han,et al.  Significance of the microbiome in obstructive lung disease , 2012, Thorax.

[55]  G. Huffnagle,et al.  The bacterial microbiota in inflammatory lung diseases. , 2015, Clinical immunology.

[56]  F. Schreiber,et al.  Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks , 2008, Gene regulation and systems biology.

[57]  I. Noth,et al.  Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy , 2015, Thorax.

[58]  Meilan K. Han,et al.  Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis , 2014, Front. Med..

[59]  I. Noth,et al.  Targeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[61]  Prescott G Woodruff,et al.  Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. , 2011, American journal of respiratory and critical care medicine.

[62]  D. Sheppard,et al.  IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction , 2012, Nature Medicine.

[63]  A. Ryan,et al.  Mitochondrial Rac1 GTPase Import and Electron Transfer from Cytochrome c Are Required for Pulmonary Fibrosis* , 2011, The Journal of Biological Chemistry.

[64]  I. Noth,et al.  Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis , 2015, European Respiratory Journal.

[65]  L. Farkas,et al.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. , 2009, The Journal of clinical investigation.

[66]  Elissa Murphy,et al.  The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.

[67]  F. Martinez,et al.  Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[68]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.